Fig 1.
CONSORT flow diagram of the clinical study.
Patient enrollment and outcomes.
Table 1.
Demographics and baseline characteristics of the patients.
Table 2.
Changes from baseline in relative insulin response (L/pmol) over the 12-week treatment period.
Table 3.
Glucose levels (mmol/L) pre-ingestion (0 minute) and changes from pre-glucose ingestion values at 30 and 120 minutes during the OGTT.
Table 4.
Insulin (pmol/L) levels pre-glucose ingestion (0 minute) and changes from pre-glucose ingestion values at 30 and 120 minutes during the OGTT.
Table 5.
Changes from lead-in period (baseline) in mean blood home glucose levels (mmol/L) over the 12-Week treatment period.
Table 6.
Changes from baseline in anthropometric and metabolic parameters at Week 12.